Focus Partners Wealth’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.94M Buy
39,256
+9,192
+31% +$728K ﹤0.01% 1213
2026
Q2
$2.38M Buy
30,064
+4,453
+17% +$378K ﹤0.01% 1282
2026
Q1
$2.24M Buy
25,611
+15,952
+165% +$1.43M ﹤0.01% 1274
2025
Q4
$843K Sell
9,659
-111,052
-92% -$8.43M ﹤0.01% 1703
2025
Q3
$9.7M Buy
+120,711
New +$6.95M 0.02% 566

Other funds holding GMED

Focus Partners Wealth's GMED Position: Q3 2026 in Review

Focus Partners Wealth increased its Globus Medical (GMED) stake by 31% in Q3 2026, buying an estimated $728K and bringing the position to 39,256 shares worth $2.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1213.

Focus Partners Wealth first reported a position in GMED in Q3 2025 and has held it in 5 quarters since. The position peaked at $9.7M in Q3 2025. 614 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • Focus Partners Wealth held 39,256 shares of Globus Medical worth $2.94M as of Q3 2026.
  • Focus Partners Wealth bought 9,192 Globus Medical shares in Q3 2026, an estimated $728K.
  • Globus Medical made up ﹤0.01% of Focus Partners Wealth's portfolio in Q3 2026, its #1213 holding.
  • Focus Partners Wealth first reported a position in Globus Medical in Q3 2025 and has held it in 5 quarters since.
  • Focus Partners Wealth's Globus Medical position peaked at $9.7M in Q3 2025.
  • 614 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on Focus Partners Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.